TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $263K of Entrada Therapeutics, Inc.
Sold$262,648
$15.01Price
17,500Shares
−38%Stake
What TRDA did after the filing
- The stock from Fri, Jun 23 close, $14.74
- −5.4%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Aug 7 close.
Traded Wed, Jun 21. Filed Fri, Jun 23, 12:20 PM ET, during the session. Returns use the Jun 23 close and the Aug 7 close. Not investment advice.